Beth Seidenberg

Beth Seidenberg

Director/Board Member at PROGYNY, INC.

Net worth: 11 M $ as of 2024-02-28

67 year
Health Technology
Technology Services
Commercial Services

Profile

Dr. Beth C. Seidenberg, MD, is a Managing Director at Westlake Biopartners LLC, an Independent Director at Vera Therapeutics, Inc., an Independent Director at Atara Biotherapeutics, Inc., a Chairman at Progyny, Inc., a Chairman at Sagimet Biosciences, Inc. and a Partner & Advisor at Kleiner Perkins Caufield & Byers LLC. She is on the Board of Directors at Expansion Therapeutics, Inc., Vera Therapeutics, Inc., Atara Biotherapeutics, Inc., ACELYRIN, Inc., Arsenal Biosciences, Inc., Auxogyn, Inc., Breathe Technologies, Inc., Cell Design Labs, Inc., Kyverna Therapeutics, Inc., Mango Health, Inc., Spruce Health, Inc., Tmunity Therapeutics, Inc. and True North Therapeutics, Inc. Dr. Seidenberg was previously employed as an Independent Director by Epizyme, Inc., a Chief Medical Officer & SVP-Global Development by Amgen, Inc., a Senior Vice President-Global Development by Bristol Myers Squibb Co., a VP-Immunology, Pulmonary & Dermatology by Merck Research Laboratories Massachusetts LLC, a Chairman by Arresto BioSciences, Inc., a Chairman by Flexus Biosciences, Inc., a Senior Executive-Research & Development by Merck & Co., Inc., and a Researcher by National Institutes of Health. She also served on the board at Practice Fusion, Inc., ARMO BioSciences, Inc., Tesaro, Inc., BioCryst Pharmaceuticals, Inc., iPierian, Inc., Livongo Health, Inc., Rapt Therapeutics, Inc. and RedBrick Health Corp. She received her undergraduate degree from Barnard College and a doctorate degree from The University of Miami Leonard M. Miller School of Medicine.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2023-06-22 264,116 ( 0.28% ) 10 M $ 2024-02-28
2023-07-17 131,643 ( 0.62% ) 806 972 $ 2024-02-28
2023-05-08 60,000 ( 0.06% ) 507 000 $ 2024-02-28
2023-05-30 116,083 ( 0.09% ) 90 313 $ 2024-02-28
2023-05-15 0 ( -.--% ) - $ 2024-02-28

Beth Seidenberg active positions

CompaniesPositionStart
SAGIMET BIOSCIENCES INC. Director/Board Member 2007-03-31
KYVERNA THERAPEUTICS, INC. Director/Board Member 2018-08-31
PROGYNY, INC. Director/Board Member 2021-12-31
ACELYRIN, INC. Director/Board Member 2020-09-30
VERA THERAPEUTICS, INC. Director/Board Member 2016-05-31
Consultant / Advisor 2005-04-30
Director/Board Member -
Director/Board Member -
Director/Board Member -
░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ -
░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ -
░░░░░░░░ ░░░░░░░░░░░ ░░░ ░░░░░░░ ░░░░░░░░░░
All active positions of Beth Seidenberg

Former positions of Beth Seidenberg

CompaniesPositionEnd
░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░░░░░░░ ░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
See the detail of Beth Seidenberg's experience

Training of Beth Seidenberg

Barnard College Undergraduate Degree
The University of Miami Leonard M. Miller School of Medicine Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Beth Seidenberg's experience

Connections

100 +

1st degree connections

39

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies11
AMGEN INC.

Health Technology

BIOCRYST PHARMACEUTICALS, INC.

Health Technology

BRISTOL-MYERS SQUIBB COMPANY

Health Technology

MERCK & CO., INC.

Health Technology

SAGIMET BIOSCIENCES INC.

Health Technology

PROGYNY, INC.

Commercial Services

RAPT THERAPEUTICS, INC.

Health Technology

KYVERNA THERAPEUTICS, INC.

Health Technology

VERA THERAPEUTICS, INC.

Health Technology

ACELYRIN, INC.

Health Technology

ATARA BIOTHERAPEUTICS, INC.

Health Technology

Private companies26

Health Technology

Health Technology

Finance

Government

Health Technology

Technology Services

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Technology Services

Commercial Services

Health Technology

Technology Services

Commercial Services

Health Technology

Health Technology

Finance

Technology Services

Finance

Health Technology

Health Technology

Health Technology

Technology Services

Health Technology

See company connections
  1. Stock
  2. Insiders
  3. Beth Seidenberg